This transcript has been edited for clarity.
Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner reporting on the recent, virtually held American Epilepsy Society meeting.
With me today is Dr Charles Szabo, professor and chief of epilepsy at the University of Texas Health Science Center at San Antonio. Dr Szabo presented a very interesting case at this year's meeting about a patient on cannabidiol (CBD) adjunctive therapy. Welcome, Dr Szabo.
Charles A. Szabo, MD: Thank you very much for inviting me.
Wilner: Tell us about your case report.
Szabo: It's about a patient with a history of epilepsy since he was 7 years old. When we reported on him, he was 63 years old. His seizures had been very well controlled for a long time. He had mainly tonic and myoclonic seizures, often in his sleep or just upon awakening, and at times during the day too.
Suddenly, when he was 57 or 58, without any clear reason or cause, his seizures started to recur more frequently. He started having more serious seizures, such as convulsive seizures.
This prompted us to try different medications. We went through a number of different options before ending up with a very unusual regimen, even for epileptologists, consisting of
COMMENTARY
A Rare Case of Status Epilepticus in a Patient Prescribed CBD
Andrew N. Wilner, MD; Charles A. Szabo, MD
DisclosuresFebruary 02, 2022
This transcript has been edited for clarity.
Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner reporting on the recent, virtually held American Epilepsy Society meeting.
With me today is Dr Charles Szabo, professor and chief of epilepsy at the University of Texas Health Science Center at San Antonio. Dr Szabo presented a very interesting case at this year's meeting about a patient on cannabidiol (CBD) adjunctive therapy. Welcome, Dr Szabo.
Charles A. Szabo, MD: Thank you very much for inviting me.
Wilner: Tell us about your case report.
Szabo: It's about a patient with a history of epilepsy since he was 7 years old. When we reported on him, he was 63 years old. His seizures had been very well controlled for a long time. He had mainly tonic and myoclonic seizures, often in his sleep or just upon awakening, and at times during the day too.
Suddenly, when he was 57 or 58, without any clear reason or cause, his seizures started to recur more frequently. He started having more serious seizures, such as convulsive seizures.
This prompted us to try different medications. We went through a number of different options before ending up with a very unusual regimen, even for epileptologists, consisting of
Medscape Neurology © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: A Rare Case of Status Epilepticus in a Patient Prescribed CBD - Medscape - Feb 02, 2022.
Tables
Authors and Disclosures
Authors and Disclosures
Authors
Andrew N. Wilner, MD
Associate Professor of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee
Disclosure: Andrew N. Wilner, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Accordant Health Services, a CVS Caremark Company
Receives royalties for: Epilepsy: 199 Answers, 3rd ed (Demos Publications) and Bullets and Brains (Createspace Independent Publishing Platform)
Charles A. Szabo, MD
Professor, Chief of Epilepsy, Department of Neurology, University of Texas Health Science Center at San Antonio; Co-director, South Texas Comprehensive Epilepsy Center, University Hospital, San Antonio, Texas
Disclosure: Charles A. Szabo, MD, has disclosed no relevant financial relationships.